Interestingly, at the same time the research group filed a patent application on G3BP as soluble biomarker for cardiovascular disease (patent application title and number: Galectin-3-Binding Protein as a Biomarker of Cardiovascular Disease, 20100055723) and recently observed that plasma G3BP correlated to mortality in coronary artery disease [62]. The gene discussed is LGALS3BP; the disease is cardiovascular disorder.